The identification of clinically significant bacteria in the laboratory and the performance of in vitro susceptibility tests provide information essential to the effective management of patients with infectious diseases (7) . During the past two decades, a variety of instrument-assisted identification and susceptibility test methods have been developed which permit generation of test results in a period of 2 to 7 h, as opposed to the 15-to 24-h time frame previously required with traditional overnight methods. These newer techniques are often referred to as "rapid" methods and, in general, have been shown to provide test results nearly as accurate as those derived from traditional overnight tests. Rapid methods are, however, more expensive. Their added cost notwithstanding, these newer rapid methods have been widely adopted in United States clinical microbiology laboratories.
In view of the added cost of rapid identification and susceptibility test methods, the question arises, what is their clinical impact? Stated another way, can the added cost of these methods be justified on the basis of some definable contribution of the method to clinical care? It has been hypothesized that rapid susceptibility testing might lead to shortened re-sponse times in cases where antibiotic therapy needs to be altered (2) . Indeed, the results of two published studies indicate that rapid susceptibility tests significantly influenced clinician usage of antibiotics (3, 6) . Other reports provide conflicting results (4) . We are aware of no published investigations that have actually attempted to systematically assess the impact of rapid susceptibility testing on infectious disease outcome. Similarly, we know of no published studies that have examined the clinical impact of rapid bacterial identification. These were the objectives of the controlled, prospective, randomized study reported herein.
MATERIALS AND METHODS
Study design. During a 1-year period, all specimens received in the University of Massachusetts Medical Center Clinical Microbiology Laboratories from hospitalized patients were assigned to one of two categories based on the first letter of the last name of the patient from whom the specimen had been obtained (A through K and L through Z). Previous experience indicated that roughly half of the laboratory's specimens came from patients in each group. Specimens were processed by standard methods. When bacteria were recovered and determined by standard laboratory criteria to merit identification and performance of in vitro susceptibility tests, such tests were performed by using a rapid 2-to 7-h instrument-assisted Only patients from whom a clinically significant isolate of Staphylococcus aureus, non-aureus staphylococci, Acinetobacter spp., or a member of the Enterobacteriaceae had been recovered from a representative specimen were included in the study. The study was restricted to patients with infections due to these organisms since we believed that at the time this study was performed, only these organisms would yield reliable susceptibility test results with the W/A system when used in the rapid mode. The first specimen from which one or more of these organisms was recovered was defined as the index positive specimen. Immediately following enrollment in the study, patients were assigned to either a third-year clinical pathology resident (R.V.) or a third-year infectious disease fellow (M.G.) for evaluation and data gathering. All study patients were followed prospectively throughout their hospitalization in the context of numerous demographic descriptors (see Tables 1 to 4) , with respect to antibiotic usage, numerous parameters of disease outcome, and cost of hospitalization (see Tables 5 to 7 Patient groups were also analyzed from the perspective of the specialty or subspecialty service primarily responsible for an individual patient's management at the time of the index positive culture (data not shown). Again, no significant differences were found.
The primary infections patients were noted to have at the time of the index positive culture are depicted in Table 2 . With one exception, no significant differences were noted between the RAST and ONAST groups. Significantly more patients (i.e., 21) in the first group had line-related bacteremia than in the second group (i.e., 15). Table 3 lists those bacteria that were isolated from index positive cultures in the two patient groups. Only minor differences between the two groups were apparent. The number of isolates of staphylococci, Acinetobacter spp., and enteric gramnegative bacilli recovered from index positive cultures exceeded the number of actual specimens in most specimen categories. This reflects the fact that selected specimens yielded more than one organism. according to length of hospitalization, both total and that SD = 14.0) was nearly identical to that observed in the following the index positive culture (Table 5) . Mortality rates, ONAST group, i.e., 23.9 h (range = 10.2 to 123; SD = 10.3).
however, both overall and those attributable to infection, were Statistically significant differences between the RAST and significantly lower in the RAST group than in the ONAST ONAST groups were, however, noted with respect to the mean group. The frequency with which microbiology tests were length of time to a definitive identification of the presumed performed on study patients was assessed, as were the numbers infecting pathogen(s) in the index positive culture and the of blood cultures obtained and the numbers of significant average time period required before susceptibility test results positive blood cultures (Table 6 ). Data were analyzed with were available. In the RAST group, these values were 11.3 h respect to entire hospitalizations and for that specific period of (range = 0.5 to 77; SD = 14.4) and 9.6 h (range = 4 to 68; SD hospitalization that followed the index positive culture. During = 13.2), respectively. In contrast, in the ONAST group, these both periods, statistically significantly fewer microbiology tests, values were 19.9 h (range = 0.5 to 101; SD = 15.5) and 25.9 h blood cultures, and positive blood cultures were noted in the (range = 16 to 78; SD = 11.0), respectively. These differences RAST group than in the ONAST group. The frequencies with were highly statistically significant (P < 0.0005).
which eight other laboratory tests were performed for the two groups were compared (Table 6 ). Again in all eight cases, the test frequency in the RAST group was significantly lower than in the ONAST group. Five different noninvasive diagnostic procedures were tracked ( Table 6 ). The frequencies with which electrocardiograms and computerized tomography (CT) scans were performed were similar in the two groups; however, ultrasound, chest X-ray, and abdominal X-ray were performed significantly less frequently in the RAST group. Finally, days of intubation and days in an intensive or intermediate-care area were compared between the two groups ( The results of an analysis of patient costs incurred during hospitalization in the two patient groups are depicted in Table  7 . Costs were lumped into one of three categories; laboratory, pharmacy, and all others. In addition, laboratory costs specifically related to microbiology and pharmacy costs specifically related to antibiotics were determined. In all five cases, costs incurred by patients in the RAST group were statistically significantly lower than those in the ONAST group. The total mean cost of hospitalization in the RAST group ($15,063) was significantly lower than the total mean cost of hospitalization in the ONAST group ($19,257) .
DISCUSSION
The intent of the current study was to assess the clinical impact of rapid bacterial identification and in vitro susceptibility testing in the setting of an academic medical center referral hospital. We are unaware of previous published studies that have examined this issue. The study was prospective in design and benefitted from a control group of patients who were found to be nearly identical to patients in the study group with respect to numerous demographic characteristics. The single salient difference between the two groups was that patients in the study group had bacterial isolates processed by using a susceptibility and identification test system which generated information on the same day tests were initiated. In the control group, the results of susceptibility test and identification procedures were available on the day following performance of the test.
A routine result reporting scheme was employed whose general features, at least, are comparable to systems used in most tertiary-care hospitals. No effort was made to expedite result reporting. Clearly, the mechanism used to report laboratory results can have a major impact on how information is used (1, 4, 6) . By using a routine, fairly typical, and widely applied result reporting scheme, we attempted to eliminate the influence of reporting as a variable on outcome. Furthermore, it was hoped that the results of this study would be generally applicable to other institutions of similar composition and scope of activities.
The two patient populations did not differ with respect to length of hospitalization. Mortality rates, however, both in general and mortality directly attributable to infection, were lower in the rapid test group than in the overnight test group. Length of hospitalization and mortality are extremely crude measures of outcome. In an attempt to examine clinical impact in a more refined manner, the frequencies of various procedures that might be related to disease outcome were compared between the two groups. Among a total of 19 different parameters, in only two cases, i.e., the frequency with which electrocardiograms and CT scans were performed, were the two patient groups found to be the same. In all other cases, significantly fewer procedures were Perhaps not surprising in view of the foregoing, the costs of hospitalization for patients in the two groups varied significantly. Laboratory costs, pharmacy costs, and other general costs were significantly lower in the rapid test group than in the overnight test group. If we amortized the cost savings to patients over a 1-year period in our institution, the total savings would have been $2,403,162.
Of interest in this study was the observation that despite an apparent impact of rapid microbiology tests on numerous parameters directly and indirectly related to disease outcome, we observed no effect on length of hospitalization. One possible explanation for this observation is that the parameters we assessed were largely related to the outcome of infectious diseases, and that in a tertiary-care teaching medical center where patient acuity is typically high, factors other than infectious disease problems have the greatest influence on length of hospitalization, the most obvious being the underlying diseases that caused patients to be hospitalized in the first place.
In conclusion, the results of the current study suggest that same-day in vitro susceptibility testing and bacterial identification can have a demonstrable clinical impact and are associated with significant cost savings for patients. In addition, rapid testing may be related to lower mortality rates in patients with infection.
